Expression of the ionotropic glutamate receptor subunits and NMDA receptor-associated intracellular proteins in the substantia nigra in schizophrenia

被引:72
作者
Mueller, HT
Haroutunian, V
Davis, KL
Meador-Woodruff, JH
机构
[1] Univ Michigan, Sch Med, Dept Psychiat, Ann Arbor, MI 48109 USA
[2] Univ Michigan, Sch Med, Mental Hlth Res Inst, Ann Arbor, MI 48109 USA
[3] Mt Sinai Sch Med, Dept Psychiat, New York, NY USA
来源
MOLECULAR BRAIN RESEARCH | 2004年 / 121卷 / 1-2期
关键词
AMPA; kainate; dopamine; neurotransmitter interactions; neuropsychiatric disease;
D O I
10.1016/j.molbrainres.2003.11.004
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Multiple neurotransmitter systems have been implicated in the pathophysiology of schizophrenia. Dopamine hyperactivity has often been implicated in this illness. More recently, the glutamate hypothesis of schizophrenia suggests that NMDA receptor (NMDAR) hypofunction may also play a role in this illness. This is based primarily on studies showing that phencyclidine, an NMDAR antagonist, can induce a schizophreniform psychosis. While NMDAR dysfunction is most often implicated in schizophrenia, other components of the glutamate system, such as the AMPA and kainate receptors, as well as NMDAR-associated intracellular proteins, may also play a role in regulating NMDA receptor activity and glutamate neurotransmission. There is growing interest in the hypothesis that the pathophysiology of schizophrenia involves alterations in dopamine-glutamate interactions. The glutamate system is anatomically and functionally linked to the dopamine system, and glutamate can modulate dopaminergic activity and release by stimulating various glutamate receptor subtypes expressed by dopaminergic neurons in the substantia nigra/ventral tegmental area. In this study, we investigated dopamine-glutamate interactions by measuring the expression of transcripts encoding the subunits for the ionotropic glutamate receptors (NMDA, AMPA and kainate) and five NMDAR-associated intracellular proteins, PSD-93, PSD-95, SA-P102, NF-L and yotiao in the dopaminergic neurons in the substantia nigra pars compacta (SNc) of subjects with schizophrenia and a comparison group. Tyrosine hydroxylase (TH, a marker of dopamine-synthesizing cells), NR1 (an NMDA receptor subunit) and GluR5 (a kainate subunit) transcript levels were significantly increased in the SNc in schizophrenia. These data support the hypothesis that schizophrenia may involve alterations in dopamine-glutamate interactions. (C) 2003 Elsevier B.V. All rights reserved.
引用
收藏
页码:60 / 69
页数:10
相关论文
共 77 条
  • [1] Immunohistochemical localization of N-methyl-D-aspartate and α-amino-3-hydroxy-5-methyl-4-isoxazolepropionate receptor subunits in the substantia nigra pars compacta of the rat
    Albers, DS
    Weiss, SW
    Iadarola, MJ
    Standaert, DG
    [J]. NEUROSCIENCE, 1999, 89 (01) : 209 - 220
  • [2] EXCITATORY AMINO-ACID BINDING-SITES IN THE BASAL GANGLIA OF THE RAT - A QUANTITATIVE AUTORADIOGRAPHIC STUDY
    ALBIN, RL
    MAKOWIEC, RL
    HOLLINGSWORTH, ZR
    DURE, LS
    PENNEY, JB
    YOUNG, AB
    [J]. NEUROSCIENCE, 1992, 46 (01) : 35 - 48
  • [3] Nucleotide sequence, genomic organization, and chromosomal localization of genes encoding the human NMDA receptor subunits NR3A and NR3B
    Andersson, O
    Stenqvist, A
    Attersand, A
    von Euler, G
    [J]. GENOMICS, 2001, 78 (03) : 178 - 184
  • [4] PARTIAL IMPROVEMENT IN NEGATIVE SCHIZOPHRENIC SYMPTOMS AFTER AMPHETAMINE
    ANGRIST, B
    PESELOW, E
    RUBINSTEIN, M
    CORWIN, J
    ROTROSEN, J
    [J]. PSYCHOPHARMACOLOGY, 1982, 78 (02) : 128 - 130
  • [5] Angrist B, 1974, Adv Biochem Psychopharmacol, V12, P211
  • [6] ANTIPSYCHOTIC DRUG-ACTION IN SCHIZOPHRENIC-PATIENTS - EFFECT ON CORTICAL DOPAMINE METABOLISM AFTER LONG-TERM TREATMENT
    BACOPOULOS, NC
    SPOKES, EG
    BIRD, ED
    ROTH, RH
    [J]. SCIENCE, 1979, 205 (4413) : 1405 - 1407
  • [7] Continuous phencyclidine treatment induces schizophrenia-like hyperreactivity of striatal dopamine release
    Balla, A
    Koneru, R
    Smiley, J
    Sershen, H
    Javitt, DC
    [J]. NEUROPSYCHOPHARMACOLOGY, 2001, 25 (02) : 157 - 164
  • [8] GluR5,6,7 subunit immunoreactivity on apical pyramidal cell dendrites in hippocampus of schizophrenics and manic depressives
    Benes, FM
    Todtenkopf, MS
    Kostoulakos, P
    [J]. HIPPOCAMPUS, 2001, 11 (05) : 482 - 491
  • [9] INCREASED BRAIN DOPAMINE AND REDUCED GLUTAMIC-ACID DECARBOXYLASE AND CHOLINE ACETYL TRANSFERASE-ACTIVITY IN SCHIZOPHRENIA AND RELATED PSYCHOSES
    BIRD, ED
    BARNES, J
    IVERSEN, LL
    SPOKES, EG
    MACKAY, AVP
    SHEPHERD, M
    [J]. LANCET, 1977, 2 (8049) : 1157 - 1159
  • [10] Bischoff S, 1997, J COMP NEUROL, V379, P541, DOI 10.1002/(SICI)1096-9861(19970324)379:4<541::AID-CNE6>3.0.CO